about
Current therapeutic strategies for advanced pancreatic cancer: A review for cliniciansPerspectives in the treatment of pancreatic adenocarcinomaNovel adjuvant therapies for pancreatic adenocarcinomaPrimary pancreatic-type acinar cell carcinoma of the jejunum with tumor thrombus extending into the mesenteric venous system: a case report and literature review.Adenocarcinoma arising from jejunal ectopic pancreas mimicking peritoneal metastasis from colon cancer: a case report and literature review.Chemoradiation therapy with S-1 for primary squamous cell carcinoma of the rectum: report of three cases.Retrospective analysis of high intensity focused ultrasound combined with S-1 in the treatment of metastatic pancreatic cancer after failure of gemcitabineClaudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway.Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts.Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies.Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma.Effect of pretreatment psoas muscle mass on survival for patients with unresectable pancreatic cancer undergoing systemic chemotherapy.Successful gamma knife radiosurgery combined with S-1 in an elderly man with local recurrent pancreatic cancer: A case report.Effect of Sipjeondaebo-Tang on the Pharmacokinetics of S-1, an Anticancer Agent, in Rats Evaluated by Population Pharmacokinetic Modeling.Health-related quality of life in a randomised phase III study of gemcitabine plus S-1, S-1 alone and gemcitabine alone for locally advanced or metastatic pancreatic cancer: GEST study.
P2860
Q26767041-D5F214E9-E3E0-4888-81DF-12FE4B3650C9Q26797248-C8A222FA-6EF9-48F2-A206-9B2D74D5D14BQ26799425-143F2F71-CEEA-4AFC-A852-C8EB6AF75B3CQ32177827-E9BC1B99-5939-4AEC-9E96-22F6326E3E04Q36289646-9573C6E7-D4D4-42D9-ABC4-FF5F85772853Q36564168-B1CEEE72-E7A1-426C-B47D-AAA5537C37B0Q36595053-8FC43774-92CD-4834-915F-7B9AD29B7E0BQ38761851-2691464F-B73C-488F-9DE6-0104C27C62C1Q39204274-14C0C0FE-C994-40EB-9B5C-3AB942A4563BQ39390859-23C51C95-F334-44BC-828C-EAABDB97DAB9Q40725730-101DC57B-09F0-4A4F-AC6B-6FD8C490A50CQ43434762-07BDEA76-7160-42F3-BCA3-3986450292FDQ47825784-569DCFC8-2BCC-4A9A-BC98-06674225C031Q50208128-C97124FB-339C-4D55-9CAD-74C2BC60FFE6Q55152175-7C67229C-1B78-40AA-8F2B-83C0CFE97AD8
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
S-1 in the treatment of pancreatic cancer.
@ast
S-1 in the treatment of pancreatic cancer.
@en
S-1 in the treatment of pancreatic cancer.
@nl
type
label
S-1 in the treatment of pancreatic cancer.
@ast
S-1 in the treatment of pancreatic cancer.
@en
S-1 in the treatment of pancreatic cancer.
@nl
prefLabel
S-1 in the treatment of pancreatic cancer.
@ast
S-1 in the treatment of pancreatic cancer.
@en
S-1 in the treatment of pancreatic cancer.
@nl
P2093
P2860
P1476
S-1 in the treatment of pancreatic cancer.
@en
P2093
Kazuyoshi Nakamura
Kentaro Sudo
Taketo Yamaguchi
P2860
P304
15110-15118
P356
10.3748/WJG.V20.I41.15110
P407
P577
2014-11-01T00:00:00Z